Published • loading... • Updated
Belgians raise 3 million euros to develop new breast cancer test
Summary by De Tijd
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
05:58 To identify breast cancer even more accurately, in order to quickly choose the right treatment, that's what Abscint aspires to. The Belgian diagnostics specialist is refuelling 3 million euros for a larger phase 2 trial...
·Belgium
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
